MYO1E and kidney disorder: This case broadens clinicopathologic recognition of <i>MYO1E</i>-associated nephropathy and highlights the teaching point that Alport-like GBM changes are not pathognomonic for type IV collagen disorders but may signal defects in podocyte cytoskeletal anchoring.